Actively Recruiting

Age: 18Years +
All Genders
ID06466902

Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastric Cancer Surgery (PhotoNodes)

Led by Azienda Ospedaliero-Universitaria di Parma · Updated on 2024-07-05

326

Participants Needed

8

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a new method to assess the quality of lymph node removal during minimally invasive surgery for gastric cancer. This observational study focuses on the PhotoNodes Score, a tool designed to rate the adequacy of D2 lymphadenectomy by examining intraoperative images taken during surgery. The goal is to find a more reliable way to measure surgical quality that may also predict patient survival. During surgery, five high-quality laparoscopic or robotic images are captured at the end of the lymphadenectomy phase before reconstruction begins. Three surgeons independently review these images and score eight specific lymph node stations from poor to excellent. These scores are averaged to create a total PhotoNodes Score for each patient, reflecting the thoroughness of the lymph node removal. Participants undergo minimally invasive gastrectomy with D2 lymphadenectomy and have their surgical images collected and reviewed. Researchers will measure agreement between observers on the scoring and examine how the score relates to disease-free survival and overall survival at 1 and 3 years. Follow-up includes medical chart reviews every six months for up to three years after enrollment ends, allowing detailed assessment of long-term outcomes and surgical quality.

CONDITIONS

Brief Title

Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients undergoing minimally invasive curative-intent surgery for gastric adenocarcinoma with D2 lymphadenectomy
  • Patients undergoing upfront surgery or treated with neoadjuvant or perioperative chemotherapy
  • Patients scheduled for total or subtotal gastrectomy
  • Surgery performed by laparoscopic or robotic approach
  • Adults aged 18 years or older
Not Eligible

You will not qualify if you...

  • Age less than 18 years
  • Esophago-gastric junction cancer Siewert type I, II, or III
  • Presence of metastatic disease
  • Lymphadenectomy less than D2
  • Open surgery or conversion to open surgery
  • Palliative gastrectomy
  • R1 or R2 tumor resection
  • Multivisceral resection except cholecystectomy
  • Surgical procedures other than subtotal or total gastrectomy
  • Any single lymph node station rated as unevaluable by more than one reviewer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery

Duration - Surgical procedure day

Participants undergo minimally invasive gastrectomy with D2 lymphadenectomy for gastric cancer. During surgery, intraoperative photographs are taken for quality assessment of the lymphadenectomy.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 3 years after enrollment

Participants' medical records are reviewed every 6 months to monitor disease-free and overall survival for up to 3 years after enrollment ends.

Medical chart reviews every 6 months

Trial Site Locations

Total: 8 locations

1

Ospedale di Cremona - UOC Chirurgia Generale

Cremona, CR, Italy, 26100

Actively Recruiting

2

Azienda Ospedaliera Universitaria Careggi - Chirurgia dell'Apparato Digerente

Florence, FI, Italy, 50134

Actively Recruiting

3

Ospedale San Raffaele - Chirurgia Gastroenterologica

Milan, MI, Italy, 20132

Not Yet Recruiting

4

Istituto Europeo di Oncologia

Milan, MI, Italy, 20139

Actively Recruiting

5

ASST Grande Ospedale Metropolitano Niguarda

Milan, MI, Italy, 20162

Actively Recruiting

6

Policlinico Abano

Abano Terme, PD, Italy, 35031

Actively Recruiting

7

Azienda Ospedaliera Universitaria Integrata Borgo Trento - Chirurgia Generale ed Esofago Stomaco

Verona, VR, Italy, 37124

Actively Recruiting

8

Azienda Ospedaliero-Universitaria di Parma

Parma, Italy, 43100

Actively Recruiting

Loading map...

Research Team

F

Federico Marchesi, Prof

G

Giorgio Dalmonte, MD, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Phase III Randomized Controlled Trial Comparing D2 Versus D3...

Gastric Cancer

Actively Recruiting

1 location

Clinical Outcomes of Indocyanine Green Tracer in 3D Plus Ult...

Gastric Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Surgical quality and prospective quality control of the D2-gastrectomy for gastric cancer in the multicenter randomized LOGICA-trial.

Cas de Jongh, Lianne Triemstra, Arjen van der Veen...

https://pubmed.ncbi.nlm.nih.gov/37651889

Surgeon Quality Control and Standardization of D2 Lymphadenectomy for Gastric Cancer: A Prospective Multicenter Observational Study (KLASS-02-QC).

Sang-Uk Han, Hoon Hur, Hyuk-Joon Lee...

https://pubmed.ncbi.nlm.nih.gov/33064386

D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial.

M Degiuli, R Reddavid, M Tomatis...

https://pubmed.ncbi.nlm.nih.gov/33887514

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.

Ilfet Songun, Hein Putter, Elma Meershoek-Klein Kranenbarg...

https://pubmed.ncbi.nlm.nih.gov/20409751

PhotoNodes Protocol: A Multicenter Prospective Study for the Assessment of Proper Lymphadenectomy in Minimally Invasive Gastric Cancer Surgery Using Intraoperative Photographs.

Federico Marchesi, Marina Valente, Simone Giacopuzzi...

https://pubmed.ncbi.nlm.nih.gov/40262552